Jonathan Hogan, MD
Disclosures: Consultant-Retrophin-Glomerular Disease/FSGS|Advisor or Review Panel Member-Zyversa-Glomerular Disease|Advisor or Review Panel Member-GlaxoSmithKline-GSK-Glomerular Disease|Grants/Research Support Recipient-Retrophin-FSGS|Grants/Research Support Recipient-Calliditas-IgA Nephropathy|Grants/Research Support Recipient-Omeros-IgA Nephropathy|Grants/Research Support Recipient-Achillion-C3 Glomerulopathy|Grants/Research Support Recipient-Gilead-Diabetic Nephropathy|Grants/Research Support Recipient-Boehringer Ingelheim Vetmedica GmbH-Diabetic Nephropathy|Grants/Research Support Recipient-GlaxoSmithKline-Diabetic Nephropathy|Grants/Research Support Recipient-Regeneron-Diabetic Nephropathy
No Bio Available.